EIGR
Eiger BioPharmaceuticals, Inc.
EIGR
EIGR
Delisted
EIGR was delisted on the 10th of April, 2024.
66 hedge funds and large institutions have $248M invested in Eiger BioPharmaceuticals, Inc. in 2014 Q4 according to their latest regulatory filings, with 30 funds opening new positions, 14 increasing their positions, 11 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
66
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$11.4M | |
| 2 | +$7.62M | |
| 3 | +$5.86M | |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$5.35M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$1.91M |
Top Sellers
| 1 | -$7.11M | |
| 2 | -$5.21M | |
| 3 | -$3.34M | |
| 4 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$2.46M |
| 5 |
Axa
Paris,
France
|
-$1.78M |